Inhibition of Growth of Human or Hamster Pancreatic Cancer Cell Lines by α-Difluoromethylornithine Alone and Combined with cis-Diamminedichloroplatinum(II)

Cancer Research

Volumn 44, Issue 11, 1984, Pages 5100-5104

  Chang, Barbara K ^a   Black, Owen ^a   Gutman, Robert ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EFLORNITHINE; PUTRESCINE;

ANIMAL MODEL; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; COLONY FORMATION; HAMSTER; HUMAN; IN VITRO STUDY; NONHUMAN; PANCREAS; PANCREAS CANCER; PRIORITY JOURNAL; THERAPY;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE; CELL SURVIVAL; CISPLATIN; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; EFLORNITHINE; HAMSTERS; HUMAN; KINETICS; ORNITHINE; PANCREATIC NEOPLASMS; PUTRESCINE; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021690650     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Abetoff, M. D., Slavik, M., Luk, G., et a/. Phase I trial and pharmacokinetic studtes of cKJKIuorometriylornithine (DFMO), an inhibitor of poiyamine biosynthesis. J. CNn. Oncol., 2; 124–130,1984.
2. Barthoteyns, J., and Koch-Weser, J. Effects of a-dffluoromethylornitrtine alone and combined with Adriamycin or vindesine on L1210 leukemia in mice, EMT6 soid tumors in mice, and sold tumors induced by injection of hepatoma tissue culture cells in rats. Cancer Res., 41:5158–5161,1981.
3. Black, O., Jr., and Chang, B. K. Ornithine decarboxylase enzyme activity in human and hamster pancreatic tumor eel Knes. Cancer Lett., 17:87–93,1982.
4. Chang, B. K. Differential sensitivity of pancreatic adenocarcinoma eel Ines to chemotherapy agents in culture. Cancer Treat. Rep., 67:355–361,1983.
5. Chang, B. K., and Black, O., Jr. Inhibition of the growth of pancreatic cancer eel lines by ã-difluorornetriyloimithe (DFMO) alone and combined with cis-diarrtminedichloroplatinum (DDP). Proc. Am. Assoc. Cancer Res., 24: 271, 1983.
6. Chang, B. K., Black, O., Jr., and Gutman, R. Schedule-dependent interaction of a-cmjorornethyloniithine (DFMO) and cfe-clarnminedttiloroplat (DDP) against pancreatic cancer eel Ines. Proc. Am. Assoc. Cancer Res., 25:316, 1984.
7. Chang, B. K., and Gutman, R. Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster. Cancer Res. 42:2666–2670,1982.
8. Chen, T. R. In situ detection of Mycoplasma contamination in eel cultures by fluorescent Hoechst 33258 stain. Exp. Cel Res., 104:255–262,1977.
9. Hung, D. T., Deen, D. F., SekJenfekJ, J., and Marton, L J. Sensitization of 9L rat brain glosarcoma eels to 1,3-bis(2-choloroethyl)-1 -nirtrosourea by a-dffluo-rornethykxnithine, an ornithine decarboxylase inhibitor. Cancer Res., 41:2783–2785,1981.
10. Kingsnorth, A. N., Russel, W. E., McCarm, P. P., Diekema, K. A., and Malt, R. A. Effects of Î-difluororietrtylornithine and 5-fluorouracl on the proMeratton of a human colon adenocarcinoma eel Hne. Cancer Res., 43:4035–4038,1983.
11. lieber, M., Mazzetta, J. A., Neison-Rees, W., Kaplan, M., and Todaro, G. Establishment of a continuous tumor-eel line (PANC-1) from a human card-noma of the exocrine pancreas. Int. J. Cancer, 15:741–747,1975.
12. Luk, Q. D., Goodwin, G., Gazdar, A. F., and BayKn, S. B. Growth-inNbitory effects of DL-Î�-diffouomethylomithine in the spectrum of human lung carcinoma eels in culture. Cancer Res., 42:3070–3073.1982.
13. Mamont, P., Duchesne, M-C., Grove, J., and Bey, P. Arrti-proMferative properties of DL-a-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem. Bfophys. Res. Com-mun., 81:68–76,1978.
14. Matsushima, M., and Bryan, G. T. Early induction of mouse urinary bladder ornithine decarboxylase activity by rodent vesical carcinogens. Cancer Res., 40:1897–1901,1980.
15. Metcalf, B. W., Bey, P., Danzin, C., ef al. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C 4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc., 700:2551–2553,1978.
16. Morgan, R. T., Woods, L. K., Moore, G. E., etã. Human cell Kne (COLO-357) of metastatic pancreatic adenocardnoma. Int. J. Cancer, 25:591–596,1980.
17. Olson, J. W., and Russell, D. H. Prolonged ornithine decarboxylase induction in regenerating carcinogen-treated liver. Cancer Res., 40:4373–4380,1980.
18. Oredsson, S. M., Deen, D. F., and Marton, L J. Decreased cytotoxicity of cis-diarfirreneclchloroplatir by o-dfluorometriylorr depletion of porvamine in 9L rat brain tumor cells in vitro. Cancer Res., 42:1296–1299,1982.
19. Pegg, A. E., and McGarm, P. P. Polyamine metabolism and function. Am. J. Physiol., 243: C212-C221,1982.
20. Poso, H., and Pegg, A. E. Effect of cnJifluoromethytorriithine on pofyamines and DMA synthesis in regenerating liver. Reversal of inhixtion of DNA synthesis by putrescine. Biochim. Btophys. Acta, 696:179–186,1982.
21. Prakash, N. J., and Sunkara, P. S. Combination chemotherapy involving o-dffluonxtiethylornithine and 1-/o-arabirKyurarK>sylcytoeine in murine L1210 leukemia. Cancer Res., 43:3192–3196.1983.
22. Roizin-Towle, L. Studies with clB
23. ScaJabrino, G., Poso, H., Hottta, E., Hannonen, P., Kato, A., and Janne, J. Synthesis and accumulation of poryamines in rat liver during chemical cardn-egenesfe. Int. J. Cancer, 21:239–245,1978.
24. Scarpei, D. G., and Rao, M. S. Transplantable ductal aadenocarcinoma of the Syrian hamster pancreas. Cancer Res., 39:452–458,1979.
25. ToMfbn, P. J., Deen, D. F., and Marton, L. J. o-Difluorofnethylomi polyamine depletion of 9L turner cats modfies drug-induced DNA cross Ink formation. Science (Wash. DC), 222:1132–1135,1983.